Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 4372-4378, September 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Portier, C. J.
Right arrow Articles by Hoel, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portier, C. J.
Right arrow Articles by Hoel, D. G.

Age-specific Models of Mortality and Tumor Onset for Historical Control Animals in the National Toxicology Program's Carcinogenicity Experiments

Christopher J. Portier, John C. Hedges and David G. Hoel

National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [C. J. P., D. G. H.], and 3398 Columbia Drive, Pittsburgh, Pennsylvania 15234 [J. C. H.]

This paper models general survival and the distribution of tumor onset times for various tumors in the data base of control animals developed by the National Toxicology Program. For general survival, a modified Weibull model is shown to give an adequate fit for both Fischer 344 rats and C57BL/6 x C3H F1 mice. In addition, data from control animals in a lifetime study of asbestos are used to support the extension of these survival curves beyond 2 years in Fischer rats. The distributions of tumor onset times are modeled using a two-parameter Weibull model. For many common tumor types, this model yielded a very good fit to the data. Finally, a summary measure of the contribution of a tumor to mortality is given.

Received 12/10/85. Revised 4/28/86. Accepted 6/ 4/86.




This article has been cited by other articles:


Home page
Toxicol SciHome page
R. L. Kodell, K. K. Lin, B. T. Thorn, and J. J. Chen
Bioassays of Shortened Duration for Drugs: Statistical Implications
Toxicol. Sci., June 1, 2000; 55(2): 415 - 432.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. A. Boorman, D. L. McCormick, J. C. Findlay, J. R. Hailey, J. R. Gauger, T. R. Johnson, R. M. Kovatch, R. C. Sills, and J. K. Haseman
Chronic Toxicity/Oncogenicity Evaluation of 60 Hz (Power Frequency) Magnetic Fields in F344/N Rats
Toxicol Pathol, May 1, 1999; 27(3): 267 - 278.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
D. L. Mccormick, G. A. Boorman, J. C. Findlay, J. R. Hailey, T. R. Johnson, J. R. Gauger, J. M. Pletcher, R. C. Sills, and J. K. Haseman
Chronic Toxicity/Oncogenicity Evaluation of 60 Hz (Power Frequency) Magnetic Fields in B6C3F1 Mice
Toxicol Pathol, May 1, 1999; 27(3): 279 - 285.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
R. L. Melnick, R. C. Sills, C. J. Portier, J. H. Roycroft, B. J. Chou, S. L. Grumbein, and R. A. Miller
Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose–response with 1,3-butadiene in mice
Carcinogenesis, May 1, 1999; 20(5): 867 - 878.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.